Perry Nicole D
Insider CIK 1657874 · APLS Vice President - Finance
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2021-08-02 | 2021-08-03 | 1,000 | — | $0 | 6,161 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2021-08-02 | 2021-08-03 | 1,000 | $3.76 | $3.8K | 5,847 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2021-08-02 | 2021-08-03 | 1,000 | $63.99 | $64.0K | 4,847 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2021-07-01 | 2021-07-02 | 1,000 | — | $0 | 7,161 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2021-07-01 | 2021-07-02 | 1,000 | $3.76 | $3.8K | 5,847 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2021-07-01 | 2021-07-02 | 1,000 | $64.00 | $64.0K | 4,847 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2021-06-11 | 2021-06-15 | 1,000 | — | $0 | 34,161 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2021-06-11 | 2021-06-15 | 1,000 | $61.56 | $61.6K | 4,847 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2021-06-11 | 2021-06-15 | 1,000 | $3.20 | $3.2K | 5,847 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2021-06-01 | 2021-06-02 | 1,000 | — | $0 | 8,161 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2021-06-01 | 2021-06-02 | 1,000 | $56.40 | $56.4K | 4,847 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2021-06-01 | 2021-06-02 | 1,000 | $3.76 | $3.8K | 5,847 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2021-05-03 | 2021-05-04 | 1,000 | — | $0 | 9,161 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2021-05-03 | 2021-05-04 | 1,000 | $3.76 | $3.8K | 5,847 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2021-05-03 | 2021-05-04 | 1,000 | $50.73 | $50.7K | 4,847 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2021-04-30 | 2021-05-03 | 1,000 | — | $0 | 10,161 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2021-04-30 | 2021-05-03 | 1,000 | $50.00 | $50.0K | 4,847 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2021-04-30 | 2021-05-03 | 1,000 | $3.76 | $3.8K | 5,847 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2021-03-01 | 2021-03-03 | 2,000 | — | $0 | 11,161 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2021-03-01 | 2021-03-03 | 2,000 | $3.76 | $7.5K | 4,347 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2021-03-01 | 2021-03-03 | 2,000 | $50.00 | $100.0K | 2,347 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | F Tax w/h | 2021-02-10 | 2021-02-11 | 153 | $47.72 | $7.3K | 2,347 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2021-02-09 | 2021-02-10 | 2,000 | — | $0 | 13,161 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2021-02-09 | 2021-02-10 | 2,000 | $50.00 | $100.0K | 2,500 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2021-02-09 | 2021-02-10 | 2,000 | $3.76 | $7.5K | 4,500 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award deriv | 2021-01-28 | 2021-02-01 | 15,000 | — | $0 | 15,000 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award | 2021-01-28 | 2021-02-01 | 2,500 | — | $0 | 2,500 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2021-01-04 | 2021-01-05 | 2,000 | — | $0 | 15,161 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2021-01-04 | 2021-01-05 | 2,000 | $3.76 | $7.5K | 2,000 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2021-01-04 | 2021-01-05 | 2,000 | $57.24 | $114.5K | 0 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2020-12-04 | 2020-12-08 | 18,000 | — | $0 | 17,161 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2020-12-04 | 2020-12-08 | 18,000 | $50.00 | $900.0K | 0 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2020-12-04 | 2020-12-08 | 18,000 | $3.76 | $67.7K | 18,000 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award deriv | 2020-02-10 | 2020-02-12 | 15,000 | — | $0 | 15,000 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award | 2020-02-10 | 2020-02-12 | 2,500 | — | $0 | 2,500 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award deriv | 2019-02-08 | 2019-02-12 | 22,000 | — | $0 | 22,000 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award deriv | 2018-02-16 | 2018-02-21 | 25,000 | — | $0 | 25,000 | SEC↗ |